New Guideline Reframes Excess Weight as Key Driver in Cardiovascular-Kidney-Metabolic Syndrome

DALLAS — The American Heart Association and the American College of Cardiology have jointly issued the first clinical guideline for cardiovascular-kidney-metabolic syndrome, or CKM syndrome, reframing excess weight — especially abdominal fat — as a key driver of interconnected health conditions that affect nearly 9 in 10 U.S. adults.

The guideline, published June 9, 2026, in Circulation, aims to shift the focus from treating individual diseases like heart disease, kidney disease, diabetes and obesity to addressing them as part of a single syndrome. It replaces the 2013 guideline for managing overweight and obesity and emphasizes that weight management is not cosmetic but a medical necessity to prevent organ damage.

“In terms of CKM health, weight is not just about a number on a scale — people with the same body weight can have very different health profiles,” said Dr. Chiadi E. Ndumele, chair of the writing committee and director of obesity and cardiometabolic research at Johns Hopkins University. “Rather, what’s most important is how fat tissue affects your metabolic health.”

The guideline urges healthcare professionals to initiate early, non-judgmental conversations about weight, starting with questions like, “Is now a good time for us to address your weight and your health and how they may be affecting each other?” This approach aims to prevent the progression of CKM syndrome, which can lead to diabetes, kidney failure, heart failure, heart attacks and strokes.

Dr. Ambar Kulshreshtha, a primary care physician and volunteer with the Heart Association, likened obesity-related inflammation to rust damaging a house’s plumbing. “The rust can damage the pipes, which is like your vascular system. It can damage the pump, which is like your heart. And it can damage the filters, like your kidneys.”

The guideline also addresses the challenge of coordinating care among specialists. “We, as either primary care clinicians or sub-specialists, operate from our own silos,” said Dr. Fatima Rodriguez, vice-chair of the writing committee and chief of preventive cardiology at Stanford University. “But people with CKM syndrome don’t experience one condition at a time — it often all hits at the same time.” The guideline recommends using CKM coordinators or navigators to improve care coordination and ensure follow-up, treating the patient as a whole person.

In addition to lifestyle interventions, the guideline outlines the use of effective medications such as SGLT2 inhibitors, GLP-1 based therapies and nonsteroidal mineralocorticoid receptor antagonists, which benefit multiple body systems. The goal, according to Ndumele, is to intervene early: “If there’s intervention earlier, I can dramatically improve my long-term outcomes.”

The American Heart Association launched the CKM Health Initiative in 2024 to improve diagnosis and treatment for the syndrome. The new guideline is expected to change how clinicians discuss weight and metabolic health, emphasizing prevention over treatment.

This news story relied on content distributed by NewMediaWire. Blockchain Registration, Verification & Enhancement provided by NewsRamp. The source URL for this press release is New Guideline Reframes Excess Weight as Key Driver in Cardiovascular-Kidney-Metabolic Syndrome.

The post New Guideline Reframes Excess Weight as Key Driver in Cardiovascular-Kidney-Metabolic Syndrome appeared first on citybuzz.